Single-cell transcriptomic insights into venetoclax response and resistance in secondary AML evolving from MDS

转录组 威尼斯人 髓样 癌症研究 生物 下调和上调 低甲基化剂 骨髓增生异常综合症 造血 髓系白血病 骨髓 CDKN2B公司 细胞培养 癸他滨 流式细胞术 白血病 伏立诺他 抗药性 免疫系统 髓系细胞 淋巴细胞生成 细胞 免疫学 基因表达谱 来那度胺 基因 基因敲除 罗咪酯肽 细胞生长 血液肿瘤 阿扎胞苷
作者
Silvia Park,Yoo‐Jin Kim,Jinho Jang,Jun Pyo Jeon,Jaewoong Lee,Hongtae Kim,Sungho Park,Semin Lee
出处
期刊:Blood [Elsevier BV]
卷期号:146 (Supplement 1): 2061-2061 被引量:1
标识
DOI:10.1182/blood-2025-2061
摘要

Abstract Background: Venetoclax (VEN), a selective BCL-2 inhibitor, has improved outcomes in AML when combined with hypomethylating agents (HMAs), particularly in older or unfit patients. However, response to VEN-based therapy in secondary AML (s-AML), especially in patients previously treated for antecedent myelodysplastic neoplasm (MDS), remains variable. The mechanisms underlying treatment resistance in this high-risk group are not well characterized. Given the cellular heterogeneity of s-AML and the limitations of bulk profiling, single-cell RNA sequencing (scRNA-seq) offers a powerful tool to dissect resistance mechanisms in specific cellular compartments such as hematopoietic stem/progenitor cells (HSPCs) and immune populations. Methods: We performed scRNA-seq on 279,211 bone marrow (BM)-derived cells from 25 samples collected from 14 s-AML patients treated with HMA/VEN at Seoul St. Mary's Hospital between February 2020 and November 2023. Samples were collected longitudinally before and after therapy. Differential transcriptomic signatures were analyzed across HSPCs, T/NK cells, and myeloid compartments. Findings were validated using flow cytometry, RT-qPCR, and a VEN-resistant SKM-1 AML cell line model. Results: scRNA-seq revealed that pre-treatment responders harbored an expanded HSPC subcluster enriched for MYC target genes, which was selectively depleted post-treatment, whereas non-responders exhibited expansion of this subcluster during therapy. Metabolic analysis showed upregulation of the serine biosynthesis pathway—particularly PHGDH and PSAT1—in non-responders. Functional validation in VEN-resistant AML cell lines confirmed that PHGDH inhibition (NCT-503) restored drug sensitivity. Immunologically, naïve CCR7⁺CD45RA⁺ CD4⁺ T cells were markedly depleted in non-responders, while immunosuppressive NEAT1⁺ CD4⁺ T cells were enriched. Similarly, pro-inflammatory monocyte/macrophage subclusters (e.g., Mono-S100A12, Mac-FCGR3A) were diminished in non-responders, who instead exhibited expansion of MALAT1⁺ monocytes and MHC-II–high immunosuppressive myeloid populations. Immune interaction analysis revealed disrupted LAIR-1 and MHC-I signaling in non-responders, suggesting impaired immune surveillance within the BM niche. Conclusion: Our findings identify HSPC-intrinsic mechanisms—specifically MYC activation and PHGDH-driven serine biosynthesis—as candidate drivers of VEN resistance in s-AML evolved from MDS. In parallel, immune dysregulation within the bone marrow microenvironment, including depletion of naïve CD4⁺ T cells and impaired LAIR-1 signaling, was associated with non-responsiveness. While these findings are based on patients with s-AML arising from MDS without direct comparison to de novo AML, they offer insight into potential mechanisms of resistance in this clinically relevant subset. These results support further investigation into metabolic and immunologic vulnerabilities and provide a rationale for developing combinatorial therapeutic strategies targeting both metabolic reprogramming and immune dysfunction to improve outcomes in VEN-treated s-AML.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
虚心灵煌完成签到,获得积分10
刚刚
刚刚
椰椰发布了新的文献求助10
1秒前
乐乐的应助被奇崽采纳,获得10
1秒前
niuniu完成签到 ,获得积分10
1秒前
L.YL发布了新的文献求助10
1秒前
Chenjunxian完成签到,获得积分10
2秒前
2秒前
现代水蓉完成签到,获得积分10
2秒前
开冲完成签到,获得积分10
3秒前
风流小鸡44完成签到,获得积分10
3秒前
秋风的应助被乐观的鞋子采纳,获得10
3秒前
霸气棉花糖完成签到,获得积分20
3秒前
xingxing发布了新的文献求助10
4秒前
曾欢完成签到,获得积分10
4秒前
葡萄狗发布了新的文献求助10
4秒前
斯文败类的应助被QQ采纳,获得10
4秒前
4秒前
5秒前
5秒前
5秒前
阿清咩完成签到 ,获得积分10
5秒前
5秒前
无限尔曼完成签到 ,获得积分10
5秒前
wangchi发布了新的文献求助10
6秒前
微笑的念梦完成签到,获得积分20
6秒前
6秒前
7秒前
7秒前
7秒前
輓楓完成签到,获得积分10
8秒前
molihuakai的应助被三笠采纳,获得10
8秒前
Wu完成签到 ,获得积分10
8秒前
Rinchemistry完成签到,获得积分10
9秒前
嘟嘟发布了新的文献求助10
9秒前
logic发布了新的文献求助10
10秒前
鱼游天下完成签到,获得积分10
10秒前
汤包发布了新的文献求助10
11秒前
风吹麦浪发布了新的文献求助10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183070
求助须知:如何正确求助?哪些是违规求助? 9572393
关于积分的说明 21824679
捐赠科研通 7779769
什么是DOI,文献DOI怎么找? 3433810
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480022